TEVA PHARMACEUTICAL INDUSTRIES LIMITED Research and Development Arrangement, Contract to Perform for Others, Compensation Earned
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Research and Development Arrangement, Contract to Perform for Others, Compensation Earned of $100.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED research and development arrangement, contract to perform for others, compensation earned for fiscal 2023 was $100.00M.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 12 month |
|---|---|
| 2023-12-31 | $100.00M 10-K · filed 2026-02-03 |